Publication date Issuer Person discharging managerial responsibilities Position Closely associated Nature of transaction Instrument name Intrument type ISIN Transaction date Volume Unit Price Currency Status Details
01/05/2020 NeuroVive Pharmaceutical AB Magnus Hansson Chief Medical Officer Subscription NeuroVive Pharmaceutical BTA BTA SE0014262408 29/04/2020 126,199 Quantity 0.80 SEK Notification
30/04/2020 NeuroVive Pharmaceutical AB Erik Kinnman VD Subscription Neurovive Pharm BTA BTA SE0014262408 29/04/2020 200,149 Quantity 0.80 SEK Notification
05/09/2019 NeuroVive Pharmaceutical AB Erik Kinnman VD Disposal NeuroVive Pharmaceutical AB Share SE0002575340 02/09/2019 21,382 Quantity 1.66 SEK Notification
05/09/2019 NeuroVive Pharmaceutical AB Erik Kinnman VD Acquisition NeuroVive Pharmaceutical AB Share SE0002575340 03/09/2019 21,382 Quantity 1.60 SEK Notification
17/02/2019 NeuroVive Pharmaceutical AB Catharina Janzon Johansson Ekonomi/finanschef Subscription NeuroVive Pharmaceutical AB BTA BTA SE0012167708 15/02/2019 25,000 Quantity 1.35 SEK Notification
11/02/2019 NeuroVive Pharmaceutical AB Erik Kinnman VD Subscription NeuroVive Pharmaceutical AB BTA BTA SE0005620341 06/02/2019 200,149 Quantity 1.35 SEK History Notification
11/02/2019 NeuroVive Pharmaceutical AB Erik Kinnman VD Acquisition NeuroVive Pharmaceutical AB BTA BTA SE0005620341 06/02/2019 200,149 Quantity 1.35 SEK Revised Notification
09/02/2019 NeuroVive Pharmaceutical AB Magnus Hansson Chief Medical Officer Subscription NeuroVive Pharmaceutical AB BTA BTA SE0005620341 06/02/2019 206,673 Quantity 1.35 SEK Notification
28/12/2018 NeuroVive Pharmaceutical AB Erik Kinnman VD Acquisition NeuroVive Pharmaceutical AB Share SE0002575340 21/12/2018 44,901 Quantity 1.32 SEK Notification
28/12/2018 NeuroVive Pharmaceutical AB Erik Kinnman VD Acquisition NeuroVive Pharmaceutical AB Share SE0002575340 27/12/2018 73,000 Quantity 1.30 SEK Notification
Showing 1 to 10 of 24 result